RDUS Prakiraan wutah bathi kanggo taun ngarep radiuspharm.com

Lambang korporat lan logo Radius Recycling (RDUS)

Radius Recycling, Inc. (RDUS) is optimizing component supplies for metabolic therapy through hub diversification. Stable turnover is driven by secondary metal recycling, while rising R&D expenditures accompany clinical drug trials. The promising EPS n+1 growth metric on the GURU.Markets chart reflects market expectations, where the value 110.10 indicates the current projected profit for the coming year.

Radius Health (RDUS): Prakiraan wutah bathi resik saben saham ing taun ngarep saka 04.07.2022 nganti 26.07.2025

RDUS (Radius Recycling Inc.): rincian analitis lan laporan miturut indikator

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:RDUS, radiuspharm.com
Produk dadi Radius Recycling

Radius Recycling, Inc. (RDUS) is expanding its presence in the osteoporosis and metabolic disorder treatment segment, aiming to increase its share of the US pharmaceutical market. This forward-looking assessment of net profit dynamics visualizes the analysts' consensus earnings per share (EPS) forecast, transforming complex models into a daily trend that allows for an evaluation of the B2B distribution scaling strategy's effectiveness and the business's fundamental resilience.

Analisis perusahaan pesaing

ASND (Ascendis) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep Madrigal Pharmaceuticals|Prakiraan wutah bathi kanggo taun ngarep CORT|Prakiraan wutah bathi resik saben saham kanggo taun ngarep RYTM (Rhythm Pharma)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep akerotx.com AKRO|Metsera Therapeutics (MTSR) - Prakiraan wutah bathi resik saben saham ing taun ngarep|MLTX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|CRNX: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|NAMS: Prakiraan wutah bathi kanggo taun ngarep|SLNO - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Amicus Corp|89bio Pharma (ETNB) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep agios.com (AGIO)|Prakiraan wutah bathi saben saham kanggo taun ngarep structuretx.com GPCR|Prakiraan wutah bathi resik saben saham kanggo taun ngarep MiMedx Group Inc MDXG|Dinamika bathi saben saham sing diarepake ing taun ngarep RZLT|lexpharma.com - Prakiraan wutah bathi kanggo taun ngarep|MBX (MBX Biosciences Inc) - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|ALT: Prakiraan wutah bathi kanggo taun ngarep|Aardvark Therapeutics Inc - Dinamika bathi saben saham sing diarepake ing taun ngarep|SGMT (Sagimet Biosciences, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep BioAge|Prakiraan wutah bathi kanggo taun ngarep BMEA|Prakiraan wutah bathi saben saham kanggo taun ngarep Quince Therapeutics, Inc. QNCX|Fractyl Health Inc. - Prakiraan wutah bathi saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep VTVT|Agape ATP Corporation - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Pluri PLUR|SYBX: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Lipocine Inc. (LPCN)|MTNB (Matinas BioPharma) - Prakiraan wutah bathi kanggo taun ngarep|sprucebiosciences.com (SPRB) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Galecto Corp (GLTO)|CTCX - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Lumos Therapeutics LUMO|Organovo Corp (ONVO) - Prakiraan wutah bathi resik saben saham ing taun ngarep